Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal Bacillus anthracis spore inhalation challenge.

Weir GM, MacDonald LD, Rajagopalan R, Sivko GS, Valderas MW, Rayner J, Berger BJ, Sammatur L, Stanford MM.

NPJ Vaccines. 2019 Feb 8;4:6. doi: 10.1038/s41541-019-0102-z. eCollection 2019.

2.

Sensitive Detection of Francisella tularensis Directly from Whole Blood by Use of the GeneXpert System.

Banada PP, Deshpande S, Chakravorty S, Russo R, Occi J, Meister G, Jones KJ, Gelhaus CH, Valderas MW, Jones M, Connell N, Alland D.

J Clin Microbiol. 2016 Dec 28;55(1):291-301. doi: 10.1128/JCM.01126-16. Print 2017 Jan.

3.

Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.

Reed MD, Wilder JA, Mega WM, Hutt JA, Kuehl PJ, Valderas MW, Chew LL, Liang BC, Squires CH.

PLoS One. 2015 Jul 24;10(7):e0130952. doi: 10.1371/journal.pone.0130952. eCollection 2015.

4.

High-throughput screening of a diversity collection using biodefense category A and B priority pathogens.

Barrow EW, Clinkenbeard PA, Duncan-Decocq RA, Perteet RF, Hill KD, Bourne PC, Valderas MW, Bourne CR, Clarkson NL, Clinkenbeard KD, Barrow WW.

J Biomol Screen. 2012 Aug;17(7):946-56. doi: 10.1177/1087057112448216. Epub 2012 May 31.

5.

Comparative study of the roles of AhpC and KatE as respiratory antioxidants in Brucella abortus 2308.

Steele KH, Baumgartner JE, Valderas MW, Roop RM 2nd.

J Bacteriol. 2010 Oct;192(19):4912-22. doi: 10.1128/JB.00231-10. Epub 2010 Jul 30.

6.

The manganese transporter MntH is a critical virulence determinant for Brucella abortus 2308 in experimentally infected mice.

Anderson ES, Paulley JT, Gaines JM, Valderas MW, Martin DW, Menscher E, Brown TD, Burns CS, Roop RM 2nd.

Infect Immun. 2009 Aug;77(8):3466-74. doi: 10.1128/IAI.00444-09. Epub 2009 Jun 1.

7.

Examination of intrinsic sulfonamide resistance in Bacillus anthracis: a novel assay for dihydropteroate synthase.

Valderas MW, Andi B, Barrow WW, Cook PF.

Biochim Biophys Acta. 2008 May;1780(5):848-53. doi: 10.1016/j.bbagen.2008.02.003. Epub 2008 Mar 10.

8.

Establishment of a method for evaluating intracellular antibiotic efficacy in Brucella abortus-infected Mono Mac 6 monocytes.

Valderas MW, Barrow WW.

J Antimicrob Chemother. 2008 Jan;61(1):128-34. Epub 2007 Nov 16.

PMID:
18024491
9.

Genetic basis for sulfonamide resistance in Bacillus anthracis.

Valderas MW, Bourne PC, Barrow WW.

Microb Drug Resist. 2007 Spring;13(1):11-20.

PMID:
17536929
10.

Newly developed colorimetric drug screening assay for Bacillus anthracis.

Barrow EW, Valderas MW, Bourne PC, Barrow WW.

Int J Antimicrob Agents. 2006 Feb;27(2):178-80. Epub 2006 Jan 19. No abstract available.

PMID:
16423510
11.

Role of HdeA in acid resistance and virulence in Brucella abortus 2308.

Valderas MW, Alcantara RB, Baumgartner JE, Bellaire BH, Robertson GT, Ng WL, Richardson JM, Winkler ME, Roop RM 2nd.

Vet Microbiol. 2005 May 20;107(3-4):307-12.

PMID:
15863292
12.

The Brucella abortus Cu,Zn superoxide dismutase is required for optimal resistance to oxidative killing by murine macrophages and wild-type virulence in experimentally infected mice.

Gee JM, Valderas MW, Kovach ME, Grippe VK, Robertson GT, Ng WL, Richardson JM, Winkler ME, Roop RM 2nd.

Infect Immun. 2005 May;73(5):2873-80.

13.

Intact purine biosynthesis pathways are required for wild-type virulence of Brucella abortus 2308 in the BALB/c mouse model.

Alcantara RB, Read RD, Valderas MW, Brown TD, Roop RM 2nd.

Infect Immun. 2004 Aug;72(8):4911-7.

14.

Adaptation of the Brucellae to their intracellular niche.

Roop RM 2nd, Bellaire BH, Valderas MW, Cardelli JA.

Mol Microbiol. 2004 May;52(3):621-30. Review.

15.
16.

Supplemental Content

Loading ...
Support Center